Giving flu nasal spray at home to families
Part of Infections, Lungs & breathing clinical trials.
This study tests whether giving the nasal flu spray (Flumist) at home to families makes it easier for more people to get vaccinated. You and your family can participate if you live in Burlington, have a child aged 2-17, and haven't had the flu shot in the last 2 years.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You live in Burlington, Ontario.
- Your household includes at least one child between 2 and 17 years old.
- You are between 2 and 59 years old.
- No one in your household has had a flu vaccine in the last 2 years.
- You are not pregnant, breastfeeding, or severely immunocompromised.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study measures how your child's body builds immunity after receiving a nasal spray flu vaccine. Researchers will collect samples to understand how the vaccine triggers the immune system to protect against influenza.
This study tests if a new nasal spray flu vaccine is safe and effective for preventing flu in healthy adults aged 18 to 59. If you've had the flu recently or have certain health conditions, this trial may not be for you.
This study tests how the immune system in your nose and airways responds to the FluMist nasal spray flu vaccine. It may help doctors understand why some people get better protection from the flu.
This study tests how healthy adults respond to the nasal flu vaccine. You may be able to help researchers learn more about how the body reacts to this vaccine.
This study looks at how your lungs and lymph nodes respond to flu infection and the nasal flu vaccine. It will help researchers understand how to create better protection against the flu.
This study tests a new investigational flu vaccine (FluMos-v2) with or without an adjuvant (ALFQ) to see how safe, tolerable, and effective it is. It may help protect against multiple flu strains.
Hear when a new Influenza (Healthy Volunteers) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.